Michelle Hastings is pioneering RNA-based therapies at Michigan Medicine, developing treatments for rare genetic diseases that are already making their way to patients. As the leader of the cutting-edge RNA Therapeutics initiative, she’s helping to redefine what’s possible in modern medicine. Discover how her work could change the way we treat disease.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.